跳至主要内容
临床试验/NCT01152229
NCT01152229已完成不适用

Platelet Reactivity In Patients With Nuisance Bleeding On A Thienopyridine

Medstar Health Research Institute1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2010年4月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
300
试验地点
1
主要终点
platelet reactivity

研究概览

简要总结

The objective is to describe and quantify levels of platelet reactivity in three different cohorts of patients taking thienopyridine: patients who report nuisance bleeding, patients who report alarming bleeding, and patients who report no nuisance or alarming bleeding. The investigators hypothesize that patients with nuisance or alarming bleeding events on maintenance thienopyridine therapy will have lower levels of platelet reactivity than patients without nuisance or alarming bleeding on thienopyridine therapy.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients 18 years or older from both genders
  • Underwent PCI within the last year
  • Taking maintenance dose of clopidogrel 75 mg once a day or prasugrel 10 mg once a day for at least five days

排除标准

  • Known allergies to aspirin, clopidogrel, or prasugrel.
  • Use of a glycoprotein (GP)IIb/IIIa inhibitor within 8 hours of the blood draw.
  • Patient known to be pregnant or lactating
  • Patient with known history of anemia, thrombocytopenia, bleeding disorder, or currently active bleeding
  • On warfarin therapy at the time of blood draw
  • Known blood transfusion within the preceding 10 days of the blood draw
  • Patients treated with non-steroidal anti-inflammatory drugs (NSAIDS, not to include aspirin) within the previous 5 days
  • Any significant medical condition that, in the investigator's opinion, may interfere with the patient's optimal participation in the study.

结局指标

主要结局

platelet reactivity

时间窗: post percutaneous coronary intervention (PCI) while still on clopidogrel

Level of platelet reactivity as assessed with the Chrono-Log Lumi-Aggregometer, which measures levels of light transmittance after stimulation with ADP to estimate levels of platelet aggregation.

次要结局

  • Platelet reactivity(post PCI while still on clopidogrel)

研究者

发起方
Medstar Health Research Institute
申办方类型
Other

研究点 (1)

Loading locations...

相似试验

Platelet Reactivity In Patients With Nuisance... | 临床试验